Retraction and Replacement of: Aftersensations and Lingering Pain After Examination in Patients with Fibromyalgia Syndrome

• August 6, 2025

Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry

• by Inigo Rua-Figueroa, Julia Martínez-Barrio, Zulema Plaza, Norman Jiménez, Maria Galindo-Izquierdo, Esther Uriarte, Antonio Fernandez-Nebro, Jaime Calvo Alen, José Rosas, Javier Narváez, Elena Aurrecoechea, Mercedes Freire, Eva Tomero, Clara Sanguesa, Carlota Iniguez, Ana Perez, Sandra Garrote, Nuria Lozano-Rivas, Oihane Ibarguengoitia, Eva Salgado, Celia Erausquin, Tarek Carlos Salman Monte, Raúl Menor, Irene Altabás-González, Jorge Fragio Gil , Joan M. Nolla, Jose M. Pego-Reigosa

• January 24, 2026

Health Resorts as an integrated community healthcare model for fibromyalgia syndrome: a strategic SWOT analysis

• by Gianluca Regazzo, Francesco Piccione, Aristide Roberto Gravina, Stefano Masiero

• May 14, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min